Fourth International Consensus Guidelines on the Management of CMV in Solid-Organ Transplantation
Transplantation · 2024
GuidelineExternal link only
Curated peer-reviewed / authoritative reference. Open the source link for the full text.
Post-transplant
ID-Transplant Multiplex Panel
Broad molecular screening for opportunistic viral, bacterial and fungal pathogens in transplant and immunocompromised patients.
Method
Real-time multiplex PCR
Turnaround
Data to be updated
Specimen
Data to be updated
Sample volume
Data to be updated
Why This Test Matters
Immunosuppressed patients face rapidly progressive opportunistic infections — CMV, EBV, invasive fungi, multidrug-resistant bacteria — that mimic rejection and drug toxicity. Early aetiological clarity changes management.
Clinical Background
Data to be updated by ID Labs scientific team.
The Diagnostic Challenge
Conventional single-pathogen approaches are slow, sample-hungry and frequently inconclusive in this syndrome.
Current Diagnostic Methods
How the ID Labs Test Helps
Broad molecular screening for opportunistic viral, bacterial and fungal pathogens in transplant and immunocompromised patients.
Test Methodology
MethodologyReal-time multiplex PCR
TechnologyData to be updated
InstrumentData to be updated
DetectionData to be updated
Specimen Information
Specimen requirements: data to be updated. Please contact ID Labs.
Specimen Container
Container information: data to be updated.
Targets / Analytes / Organisms
Viruses
CytomegalovirusEpstein–Barr VirusBK virusJC virusHHV-6AdenovirusHerpes Simplex Virus 1Herpes Simplex Virus 2Varicella-Zoster VirusAdditional viral targets — data to be updated
Bacteria / Mycobacteria
Parasites
Technical Performance
| Characteristic | Value | Source |
|---|---|---|
| Target count | 16 pathogen targets across 4 groups (standard panel composition; to be confirmed by ID Labs) | ID Labs Specification |
| Analytical / clinical performance | Performance characteristics: please contact ID Labs — data to be updated. | ID Labs Validated Performance |
Clinical Utilization
Data to be updated. Test selection must be made by the treating clinician.
Limitations
- Panel configuration and validated target list: data to be updated
- Molecular detection requires clinical correlation
- Culture remains necessary where viable organisms or susceptibility testing are required
Publications & Scientific Evidence
Quantitative CMV nucleic-acid testing for viral-load monitoring in transplant recipients
PMC (peer-reviewed review) · 2024
ReviewExternal link only
Curated peer-reviewed / authoritative reference. Open the source link for the full text.
Related Tests & Technologies
panel
ID-Neurology Multiplex Panel
Rapid molecular investigation of multiple pathogens associated with meningitis and encephalitis from a single CSF sample.
panel
ID-Sepsis Multiplex Panel
Rapid detection of more than 30 sepsis-causing pathogens and their drug-resistance markers directly from whole blood.
panel
ID-Fever / PUO Multiplex Panel
Simultaneous detection of viruses, parasites and bacteria causing acute febrile illness and pyrexia of unknown origin from one sample.
panel
ID-Respiratory Multiplex Panel
Comprehensive viral and bacterial respiratory pathogen detection from swabs, sputum or BAL in a single multiplex assay.
panel
ID-Pediatric Multiplex Panel
Rapid syndromic testing tailored to febrile and seriously ill children, designed around small sample volumes.
panel
ID-STI Multiplex Panel
Molecular detection of common sexually transmitted pathogens from a single urogenital specimen.
Frequently Asked Questions
Discuss this test with our scientific team
Panel configuration, specimen logistics and turnaround details on request.
Information on this page is educational and does not replace professional clinical judgment. Performance values are labelled by source (ID Labs Specification / ID Labs Validated Performance / Manufacturer Specification / Published Scientific Evidence). Molecular results must be correlated clinically and, where appropriate, confirmed by culture and phenotypic susceptibility testing.